Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00391482 · ClinicalTrials.gov registry record · Phase 2
Study to Reduce Intravenous Exposures (STRIVE)
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 750
- Enrollment target
NCT00391482 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 750 participants.
The verdict
NCT00391482, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 750 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a six-session, small group behavioral intervention based on "peer-volunteer activism" is effective in (1) decreasing distributive sharing of syringes and other injection paraphernalia and (2) increasing utilization of HCV-related healthcare services among HCV-infected injection drug users
Interventions
- BEHAVIORAL Peer Mentoring Intervention for HCV-Infected IDUs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2002-06 |
| Est. Completion | 2005-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00391482
The ClinicalTrials.gov registry entry for NCT00391482 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peer Mentoring Intervention for HCV-Infected IDUs is the first listed.
NCT00391482 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00391482 about?
NCT00391482 is a clinical study titled "Study to Reduce Intravenous Exposures (STRIVE)". The purpose of this study is to determine whether a six-session, small group behavioral intervention based on "peer-volunteer activism" is effective in (1) decreasing distributive sharing of syringes and other injection paraphernalia and (2) increasing utilization of HCV-related healthcare services ...
What is the current status of trial NCT00391482?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 750 participants. The study started on 2002-06. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00391482?
The interventions under investigation include: Peer Mentoring Intervention for HCV-Infected IDUs (BEHAVIORAL).
Who is sponsoring clinical trial NCT00391482?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.